Published peptide research references
Contulakin-G
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Conotoxin contulakin-G engages a neurotensin receptor 2/R-type calcium channel (Cav2.3) pathway to mediate spinal antinociception.
DOI: 10.1097/j.pain.0000000000002561
Source identity and connection checked by Codex (AI).
Contulakin-G, an O-glycosylated invertebrate neurotensin.
Source identity and connection checked by Codex (AI).
The conotoxin Contulakin-G reverses hypersensitivity observed in rodent models of cancer-induced bone pain without inducing tolerance or motor disturbance.
DOI: 10.1097/j.pain.0000000000003391
Source identity and connection checked by Codex (AI).
The pharmacokinetics of the conopeptide contulakin-G (CGX-1160) after intrathecal administration: an analysis of data from studies in beagles.
DOI: 10.1213/01.ane.0000262038.58546.e6
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Martin LF
- Almuslim M
- Ismail KA
- Ibrahim MM
- Moutal A
- Cheng K
- Stratton HJ
- Price TJ
- Vanderah TW
- Olivera BM
- Khanna R
- Patwardhan A
- Craig AG
- Norberg T
- Griffin D
- Hoeger C
- Akhtar M
- Schmidt K
- Low W
- Dykert J
- Richelson E
- Navarro V
- Mazella J
- Watkins M
- Hillyard D
- Imperial J
- Cruz LJ
- Kern SE
- Allen J
- Wagstaff J
- Shafer SL
- Yaksh T
- Martin L
- Ibrahim M
- Gomez K
- Yu J
- Cai S
- Chew LA
- Bellampalli SS
- Largent-Milnes T
- Porreca F